Thrombolytic therapy: 2001.
Marder
V J
VJ
Vascular Medicine Program, Los Angeles Orthopaedic Hospital and Hematology/Medical Oncology Division, Department of Medicine, UCLA School of Medicine, USA. vmarder@laoh.ucla.edu
D000818:Animals; D002986:Clinical Trials as Topic; D000075202:Contraindications; D005343:Fibrinolytic Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D006470:Hemorrhage / Q000139:chemically induced / Q000628:therapy; D006801:Humans; D015912:Thrombolytic Therapy / Q000009:adverse effects / Q000379:methods*; D014652:Vascular Diseases / Q000150:complications / Q000188:drug therapy / Q000401:mortality
D005343:Fibrinolytic Agents